About

Gilead Sciences, Inc., an American biopharmaceutical company headquartered in Foster City, California, was founded on June 22, 1987. Specializing in researching and developing antiviral drugs, its comprehensive product portfolio addresses treatments for HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, notably including ledipasvir/sofosbuvir and sofosbuvir. The company, which operates in the pharmaceutics and biotechnology industries, reported a substantial revenue of US$ 28.75 billion in 2024. As a public entity, Gilead holds a significant market position, being a member of both the Nasdaq-100 and the S&P 100.